6
Participants
Start Date
May 4, 2018
Primary Completion Date
August 19, 2019
Study Completion Date
August 19, 2019
GeneSight Psychotropic test
GeneSight Psychotropic test, developed by AssureRx Health, is a genetic test that analyses pre-selected pharmacokinetics and pharmacodynamics genes and results in a composite phenotype and interpretive report, addressing both safety and efficacy of psychiatric medications.
FDA-approved antidepressant or antipsychotic treatment
Participant is treated with medications included in the GeneSight Psychotropic product.
Washington University School of Medicine, St Louis
Collaborators (1)
AssureRx Health, Inc.
INDUSTRY
Washington University School of Medicine
OTHER